Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities
Biotechnology Progress June 18, 2024 Xin Wang, Fiona C. Kanis, Caroline N. Broude et al. 2 citations
Abstract N ‐methylated tryptamines, such as the hallucinogenic natural products, psilocybin and N,N ‐dimethyltryptamine (DMT), are gaining interest from the medical community due to their potential as next generation treatments for mental health disorders. The clinical relevance of these compounds has driven scientists to develop biosynthetic production routes to a number of tryptamine drug...